









Markets
/
Stocks
/
nasdaq-sem
/

Select Medical Holdings Corp

SEM

13.440USD

+0.080+0.60%

Close 11/11, 16:00（ET）Quotes delayed by 15 min

1.66BMarket Cap

14.61P/E TTM



Select Medical Holdings Corp

13.440

+0.080+0.60%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Select Medical Holdings Corp

Currency: USD Updated: 2025-11-11

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Select Medical Holdings Corp's Score

Industry at a Glance

Industry Ranking

30 / 78

Overall Ranking

161 / 4608

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 6 analysts

Buy

Current Rating

18.167

Target Price

+35.98%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Select Medical Holdings Corp Highlights

StrengthsRisks

Select Medical Holdings Corporation is an operator of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Company’s segments include the critical illness recovery hospital, the rehabilitation hospital, and the outpatient rehabilitation. Its critical illness recovery hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs, and its rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Its outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. The Company operates about 106 critical illness recovery hospitals in 29 states, 34 rehabilitation hospitals in 13 states, and 1,925 outpatient rehabilitation clinics in 39 states and the District of Columbia.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 5.19B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 102.32%.

Overvalued

The company’s latest PE is 15.38, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 101.41M shares, decreasing 11.58% quarter-over-quarter.

Held by Chuck Royce

Star Investor Chuck Royce holds 400.20K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-11

The company's current financial score is 8.24, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 1.36B, representing a year-over-year decrease of 22.59%, while its net profit experienced a year-over-year decrease of 47.48%.

Score

Industry at a Glance

Previous score

8.24

Change



Financials

5.86

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.78

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.58

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

8.97

Key Metrics

Free cash flow

No Data

Select Medical Holdings Corp's Company Valuation

Currency: USD Updated: 2025-11-11

The company’s current valuation score is 6.25, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 15.38, which is 0.22% below the recent high of 15.41 and 58.53% above the recent low of 6.38.

Score

Industry at a Glance

Previous score

6.25

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 30/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-11

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Providers & Services industry's average of 7.56. The average price target for Select Medical Holdings Corp is 18.50, with a high of 21.00 and a low of 14.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 6 analysts

Buy

Current Rating

18.167

Target Price

+35.98%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Select Medical Holdings Corp

SEM

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-11

The company’s current price momentum score is 6.89, which is lower than the Healthcare Providers & Services industry's average of 7.10. Sideways: Currently, the stock price is trading between the resistance level at 14.45 and the support level at 12.65, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.76

Change

0.13

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.214

Neutral

RSI(14)

47.565

Neutral

STOCH(KDJ)(9,3,3)

30.328

Neutral

ATR(14)

0.507

High Vlolatility

CCI(14)

-52.809

Neutral

Williams %R

68.333

Sell

TRIX(12,20)

0.089

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

13.384

Buy

MA10

13.602

Sell

MA20

13.762

Sell

MA50

13.216

Buy

MA100

13.512

Sell

MA200

15.140

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-11

The company’s current institutional recognition score is 7.00, which is lower than the Healthcare Providers & Services industry's average of 7.03. The latest institutional shareholding proportion is 81.89%, representing a quarter-over-quarter decrease of 20.71%. The largest institutional shareholder is PRFDX, holding a total of 16.02M shares, representing 12.94% of shares outstanding, with 1.82% decrease in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

T. Rowe Price Associates, Inc.

Star Investors

16.02M

-6.17%

BlackRock Institutional Trust Company, N.A.

15.99M

-3.01%

The Vanguard Group, Inc.

Star Investors

12.90M

-2.85%

Ortenzio (Robert A)

9.20M

+2.79%

Dimensional Fund Advisors, L.P.

4.99M

+18.35%

State Street Investment Management (US)

4.25M

+1.33%

Rocco A. Ortenzio UEO

4.09M

-48.22%

T. Rowe Price Investment Management, Inc.

3.60M

-10.65%

Geode Capital Management, L.L.C.

3.04M

+2.72%

Principal Global Investors (Equity)

2.92M

+18.09%

Risk Assessment

Currency: USD Updated: 2025-11-11

The company’s current risk assessment score is 5.79, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 1.29. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.